IN2012DN01449A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01449A IN2012DN01449A IN1449DEN2012A IN2012DN01449A IN 2012DN01449 A IN2012DN01449 A IN 2012DN01449A IN 1449DEN2012 A IN1449DEN2012 A IN 1449DEN2012A IN 2012DN01449 A IN2012DN01449 A IN 2012DN01449A
- Authority
- IN
- India
- Prior art keywords
- diagnostic
- blood vessels
- conditions associated
- pathological conditions
- cancerous tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1234—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200900879 | 2009-07-17 | ||
US30078210P | 2010-02-02 | 2010-02-02 | |
EP10152394 | 2010-02-02 | ||
PCT/DK2010/050192 WO2011006510A1 (en) | 2009-07-17 | 2010-07-16 | Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01449A true IN2012DN01449A (nl) | 2015-06-05 |
Family
ID=43448962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1449DEN2012 IN2012DN01449A (nl) | 2009-07-17 | 2010-07-16 |
Country Status (7)
Country | Link |
---|---|
US (2) | US8920775B2 (nl) |
EP (1) | EP2453927B1 (nl) |
JP (1) | JP5872466B2 (nl) |
AU (1) | AU2010272957B2 (nl) |
CA (1) | CA2768444A1 (nl) |
IN (1) | IN2012DN01449A (nl) |
WO (1) | WO2011006510A1 (nl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5947807B2 (ja) | 2010-12-14 | 2016-07-06 | テクニカル ユニバーシティ オブ デンマークTechnical University Of Denmark | ナノ粒子組成物への放射性核種の封入 |
AU2013249307B2 (en) | 2012-04-17 | 2017-11-09 | Merrimack Pharmaceuticals, Inc. | Compositions and methods for non-invasive imaging |
US9480759B2 (en) * | 2012-11-21 | 2016-11-01 | Serene, Llc | Tin-117m somatostatin receptor binding compounds and methods |
US20160022842A1 (en) * | 2013-03-11 | 2016-01-28 | Wayne State University | Formation and uses of europium |
US10781178B2 (en) | 2015-08-12 | 2020-09-22 | The General Hospital Corporation | 8-hydroxyquinoline derivatives as diagnostic and therapeutic agents |
US11633502B2 (en) | 2016-03-07 | 2023-04-25 | Memorial Sloan Kettering Cancer Center | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use |
US20220023450A1 (en) * | 2018-09-11 | 2022-01-27 | Memorial Sloan Kettering Cancer Center | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use |
US11478493B2 (en) * | 2019-03-08 | 2022-10-25 | University Of South Carolina | Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers |
WO2023240135A2 (en) | 2022-06-07 | 2023-12-14 | Actinium Pharmaceuticals, Inc. | Bifunctional chelators and conjugates |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0386146B1 (en) | 1987-11-04 | 1993-04-28 | Vestar, Inc. | Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
US5688488A (en) | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5525232A (en) * | 1990-03-02 | 1996-06-11 | The Liposome Company, Inc. | Method for entrapment of cationic species in lemellar vesicles |
JPH075561B2 (ja) | 1991-12-17 | 1995-01-25 | 工業技術院長 | α−アミノ酸のジアミド誘導体 |
US5837282A (en) * | 1996-10-30 | 1998-11-17 | University Of British Columbia | Ionophore-mediated liposome loading |
US6306393B1 (en) * | 1997-03-24 | 2001-10-23 | Immunomedics, Inc. | Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
US5945502A (en) | 1997-11-13 | 1999-08-31 | Xerox Corporation | Electroluminescent polymer compositions and processes thereof |
NO312708B1 (no) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
DE10012782A1 (de) * | 2000-03-16 | 2001-09-20 | Boellhoff Gmbh | Verbindungsanordnung zum Anbringen eines Befestigungselementes an einem Bauteil |
EP1616182A4 (en) * | 2003-03-18 | 2008-04-16 | Ethicon Inc | REPLACEMENT ENZYMOTHERAPY WITH 17-BETA-HYDROXYSTEROID DESHYDROGENASE TYPE 2 |
WO2004082626A2 (en) | 2003-03-18 | 2004-09-30 | Ethicon, Inc. | Aromatase inhibitor diagnosis and therapy |
WO2006021008A2 (en) | 2004-08-20 | 2006-02-23 | Lind Stuart E | Ionophores as cancer chemotherapeutic agents |
EP1796729A4 (en) * | 2004-10-06 | 2010-12-08 | Bc Cancer Agency | LIPOSOME WITH IMPROVED ARZNE RETENTION FOR THE TREATMENT OF CANCER |
GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
ITMI20050328A1 (it) | 2005-03-03 | 2006-09-04 | Univ Degli Studi Milano | Composti peptidomimetrici e preparazione di derivati biologicamente attivi |
CA2648099C (en) * | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
TW200922630A (en) | 2007-09-26 | 2009-06-01 | Nat Health Research Institutes | Liposome compositions useful for tumor imaging and treatment |
WO2009140215A2 (en) | 2008-05-11 | 2009-11-19 | Geraghty, Erin | Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds |
BR112014010291A2 (pt) * | 2011-10-31 | 2017-04-18 | Mallinckrodt Llc | composições de lipossoma combinacionais para terapia de câncer |
-
2010
- 2010-07-16 EP EP10799456.8A patent/EP2453927B1/en not_active Not-in-force
- 2010-07-16 JP JP2012519888A patent/JP5872466B2/ja not_active Expired - Fee Related
- 2010-07-16 WO PCT/DK2010/050192 patent/WO2011006510A1/en active Application Filing
- 2010-07-16 CA CA2768444A patent/CA2768444A1/en not_active Abandoned
- 2010-07-16 IN IN1449DEN2012 patent/IN2012DN01449A/en unknown
- 2010-07-16 AU AU2010272957A patent/AU2010272957B2/en not_active Ceased
- 2010-07-16 US US13/383,310 patent/US8920775B2/en not_active Expired - Fee Related
-
2014
- 2014-12-22 US US14/579,552 patent/US20150202336A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5872466B2 (ja) | 2016-03-01 |
JP2012533523A (ja) | 2012-12-27 |
US20120213698A1 (en) | 2012-08-23 |
WO2011006510A1 (en) | 2011-01-20 |
US8920775B2 (en) | 2014-12-30 |
EP2453927B1 (en) | 2019-05-15 |
EP2453927A1 (en) | 2012-05-23 |
US20150202336A1 (en) | 2015-07-23 |
CA2768444A1 (en) | 2011-01-20 |
AU2010272957B2 (en) | 2016-03-03 |
EP2453927A4 (en) | 2013-01-23 |
AU2010272957A1 (en) | 2012-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN01449A (nl) | ||
Caudell et al. | The future of personalised radiotherapy for head and neck cancer | |
You et al. | Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma–A case-matched comparison | |
Castaldi et al. | Can “early” and “late” 18F-FDG PET–CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? | |
WO2008008483A3 (en) | Dendrimer based compositions and methods of using the same | |
NZ605674A (en) | X-ray imaging at low contrast agent concentrations and/or low dose radiation | |
WO2013089882A3 (en) | Recurrent gene fusions in breast cancer | |
WO2014205555A8 (en) | Methods and uses for diagnosis and treatment of prostate cancer | |
EP3208615A3 (en) | Uses of labeled hsp90 inhibitors | |
WO2012012750A8 (en) | Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery | |
MX2015001716A (es) | Niclosamida para el tratamiento de tumores solidos. | |
NZ710436A (en) | Biospecific agents for bone | |
Li et al. | Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients | |
CO6382138A2 (es) | N-cadherina: blanco para diagnosis y terapia de cáncer | |
GB201121914D0 (en) | Method for patient selection | |
Demirci et al. | The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer | |
De Waele et al. | Response assessment of hormonal therapy in prostate cancer by [11C] choline PET/CT | |
MX340487B (es) | Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. | |
MX2008016493A (es) | Metodo para la deteccion de diagnostico de cancer que implica cebadores y sondas para la deteccion especifica del marcador mage-3. | |
WO2007136856A3 (en) | Heyl as a therapeutic target and a diagnostic marker for neoplasia and uses therefor | |
UA56157U (ru) | Способ предоставления помощи больным с пост-травматической отоликвореей в остром периоде черепно-мозговой травмы при переломах височной кости | |
UA60606U (ru) | Способ стереотаксической биопсии очаговых образований головного мозга глубинной локализации | |
MX336321B (es) | 99mtc-tat-bombesina como un nuevo radiofarmaco para la deteccion temprana de cancer de mama. | |
Emmett et al. | Imaging for melanoma and non-melanoma skin cancers | |
Jung et al. | False-positive F-18 FDG PET/CT from foreign body reaction on anterior chest wall after endoscopic total thyroidectomy via axillo-breast approach for thyroid cancer: two case reports |